Athersys Company Profile (NASDAQ:ATHX)

About Athersys

Athersys logoAthersys, Inc. is an international biotechnology company that is focused primarily in the field of regenerative medicine. The Company's MultiStem cell therapy, an allogeneic stem cell product, is its lead platform product and is in later-stage clinical development. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the standard of care is limited or inadequate for many patients. In the neurological area, the Company evaluated in a completed Phase II trial, the potential for MultiStem treatment of patients with a history of neurological damage from an ischemic stroke. The Company initiated a Phase II clinical study in the United States for the administration of MultiStem cell therapy to patients with a history of an acute myocardial infarction, or AMI.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ATHX
  • CUSIP:
Key Metrics:
  • Previous Close: $1.96
  • 50 Day Moving Average: $1.97
  • 200 Day Moving Average: $2.19
  • 52-Week Range: $0.94 - $2.90
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.36
  • P/E Growth: -0.33
  • Market Cap: $172.51M
  • Outstanding Shares: 84,982,000
Profitability:
  • Net Margins: -18.89%
  • Return on Equity: -25.42%
  • Return on Assets: -17.54%
Debt:
  • Current Ratio: 4.47%
  • Quick Ratio: 4.47%
Additional Links:
Companies Related to Athersys:

Analyst Ratings

Consensus Ratings for Athersys (NASDAQ:ATHX) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.50 (361.17% upside)
Analysts' Ratings History for Athersys (NASDAQ:ATHX)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Maxim GroupReiterated RatingBuy$10.00View Rating Details
1/10/2016WBB SecuritiesReiterated RatingBuy$9.00View Rating Details
7/10/2015Piper Jaffray Cos.DowngradeOverweight -> HoldView Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Athersys (NASDAQ:ATHX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/9/2016Q216($0.10)($0.08)$0.32 million$0.60 millionViewN/AView Earnings Details
5/5/2016Q1($0.08)$0.06$1.85 million$15.45 millionViewN/AView Earnings Details
3/10/2016Q4($0.09)$0.04$3.72 million$10.61 millionViewListenView Earnings Details
11/5/2015Q315($0.07)($0.08)$1.75 million$0.40 millionViewListenView Earnings Details
8/6/2015Q2($0.08)($0.05)$2.66 million$0.22 millionViewN/AView Earnings Details
5/11/2015Q115($0.07)($0.16)$2.01 million$0.73 millionViewListenView Earnings Details
3/12/2015Q414($0.10)($0.08)$0.50 million$0.24 millionViewN/AView Earnings Details
11/10/2014Q314($0.09)($0.06)$0.54 million$0.29 millionViewN/AView Earnings Details
8/11/2014Q214($0.09)$0.01$0.70 million$0.40 millionViewN/AView Earnings Details
5/8/2014Q114($0.10)($0.09)$0.66 million$0.71 millionViewN/AView Earnings Details
3/13/2014Q413($0.11)($0.15)$1.81 million$0.92 millionViewN/AView Earnings Details
11/14/2013Q3($0.12)($0.10)$0.49 million$0.62 millionViewListenView Earnings Details
8/13/2013Q2 2013($0.12)($0.11)$390.00 million$0.57 millionViewN/AView Earnings Details
5/14/2013Q1 2013($0.11)($0.18)$1.58 million$0.33 millionViewN/AView Earnings Details
11/8/2012Q312($0.13)($0.12)$2.51 million$1.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Athersys (NASDAQ:ATHX)
Current Year EPS Consensus Estimate: $-0.21 EPS
Next Year EPS Consensus Estimate: $-0.28 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.05)($0.05)($0.05)
Q2 20161($0.09)($0.09)($0.09)
Q3 20161($0.11)($0.11)($0.11)
Q4 20161($0.11)($0.11)($0.11)
Q1 20171($0.07)($0.07)($0.07)
Q2 20171($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Athersys (NASDAQ:ATHX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Athersys (NASDAQ:ATHX)
Insider Ownership Percentage: 10.90%
Institutional Ownership Percentage: 17.76%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/19/2016William Lehmann JrInsiderSell3,000$1.96$5,880.00View SEC Filing  
9/16/2016John J HarringtonEVPSell15,000$1.96$29,400.00View SEC Filing  
6/21/2016William Lehmann JrCOOSell25,000$2.17$54,250.00View SEC Filing  
3/21/2016William Lehmann JrCOOSell25,000$2.41$60,250.00View SEC Filing  
12/21/2015William Lehmann, Jr.COOSell25,000$1.03$25,750.00View SEC Filing  
9/21/2015Bokkelen Gil VanCEOSell9,500$1.36$12,920.00View SEC Filing  
9/21/2015John J. HarringtonEVPSell8,150$1.36$11,084.00View SEC Filing  
9/21/2015William Lehmann, Jr.COOSell25,000$1.36$34,000.00View SEC Filing  
6/22/2015William Lehmann JrCOOSell25,000$1.21$30,250.00View SEC Filing  
6/19/2015John J HarringtonInsiderSell8,150$1.23$10,024.50View SEC Filing  
6/19/2015Robert J DeansEVPSell5,080$1.23$6,248.40View SEC Filing  
6/9/2015Kenneth H TraubDirectorBuy30,000$1.27$38,100.00View SEC Filing  
3/20/2015William Lehmann JrCOOSell25,000$3.14$78,500.00View SEC Filing  
3/19/2015Bokkelen Gil VanCEOSell9,500$3.10$29,450.00View SEC Filing  
3/19/2015Robert J DeansEVPSell5,080$3.10$15,748.00View SEC Filing  
12/19/2014Bokkelen Gil VanCEOSell9,500$1.29$12,255.00View SEC Filing  
12/19/2014Robert J DeansEVPSell5,080$1.28$6,502.40View SEC Filing  
12/19/2014William Lehmann JrCOOSell30,000$1.29$38,700.00View SEC Filing  
9/24/2014Kenneth H TraubDirectorBuy30,000$1.39$41,700.00View SEC Filing  
9/22/2014William Lehmann JrCOOSell30,000$1.40$42,000.00View SEC Filing  
9/19/2014Bokkelen Gil VanCEOSell9,500$1.41$13,395.00View SEC Filing  
9/19/2014John J HarringtonInsiderSell8,150$1.41$11,491.50View SEC Filing  
9/19/2014Robert J DeansEVPSell5,080$1.41$7,162.80View SEC Filing  
8/18/2014Lorin RandallDirectorSell15,000$1.54$23,100.00View SEC Filing  
6/20/2014William Lehmann JrCOOSell12,000$1.58$18,960.00View SEC Filing  
6/19/2014Bokkelen Gil VanCEOSell9,500$1.63$15,485.00View SEC Filing  
6/19/2014John J HarringtonInsiderSell8,150$1.63$13,284.50View SEC Filing  
6/19/2014Robert J DeansEVPSell5,080$1.63$8,280.40View SEC Filing  
6/19/2014William Lehmann JrCOOSell13,000$1.62$21,060.00View SEC Filing  
3/20/2014William Lehmann JrCOOSell25,000$3.62$90,500.00View SEC Filing  
3/18/2014Bokkelen Gil VanCEOSell9,500$3.54$33,630.00View SEC Filing  
3/18/2014John J HarringtonInsiderSell8,150$3.54$28,851.00View SEC Filing  
3/18/2014Robert J DeansEVPSell5,080$3.54$17,983.20View SEC Filing  
12/20/2013William Lehmann JrCOOSell25,000$2.13$53,250.00View SEC Filing  
12/11/2013Kenneth H TraubDirectorBuy20,000$1.94$38,800.00View SEC Filing  
9/20/2013John J HarringtonInsiderSell30,000$1.82$54,600.00View SEC Filing  
9/20/2013William Lehmann JrCOOSell12,000$1.83$21,960.00View SEC Filing  
11/28/2012Laura K CampbellVPBuy10,000$1.01$10,100.00View SEC Filing  
11/15/2012Robert J DeansEVPBuy3,500$0.99$3,465.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Athersys (NASDAQ:ATHX)
DateHeadline
streetinsider.com logoPre-Open Stock Movers 09/28: (SEED) (AVXL) (ATHX) Higher; (GALT) (TPX) (SONC) Lower (more...) - StreetInsider.com (NASDAQ:ATHX)
www.streetinsider.com - September 28 at 3:34 PM
News IconInterested Penny Stock Investors Keen on Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 28 at 3:34 PM
smarteranalyst.com logoStock Update (NASDAQ:ATHX): Here's Why Athersys, Inc. Shares Are Up 15% - Smarter Analyst (NASDAQ:ATHX)
www.smarteranalyst.com - September 28 at 3:34 PM
News IconPenny Stock Investors are Growing Curious About Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 28 at 8:25 AM
streetinsider.com logoAthersys (ATHX) Receives FDA Okay Under a SPA for Phase 3 Study of MultiStem - StreetInsider.com (NASDAQ:ATHX)
www.streetinsider.com - September 28 at 8:25 AM
News IconAthersys, Inc. (ATHX) Latest Broker Coverage - NewsDen (NASDAQ:ATHX)
newsden.net - September 28 at 8:25 AM
publicnow.com logoAthersys Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Study of MultiStem® Treatment for Ischemic Stroke (NASDAQ:ATHX)
www.publicnow.com - September 28 at 8:25 AM
News IconUnder the Microscope: Zeroing in on Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 27 at 8:10 AM
News IconConsensus Take: Athersys, Inc. (NASDAQ:ATHX) Earnings & Ratings Watch - Frisco Fastball (NASDAQ:ATHX)
friscofastball.com - September 26 at 3:45 PM
News IconKeen Investors Find News on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 24 at 8:56 AM
investornewswire.com logoShares Of Athersys, Inc. (NASDAQ:ATHX) Expected To Hit $10 - Investor Newswire (NASDAQ:ATHX)
www.investornewswire.com - September 23 at 8:39 AM
News IconWhat are Analysts Expecting for Athersys, Inc. (NASDAQ:ATHX) Earnings? - Frisco Fastball (NASDAQ:ATHX)
friscofastball.com - September 23 at 8:39 AM
News IconUnder the Microscope, Zeroing in at Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 23 at 8:39 AM
News IconPenny Stock Investors Keen on Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 22 at 9:31 AM
News IconPenny Stock Investors Take an Interest in Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 20 at 3:37 PM
News IconKeen Investors Seek Information on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 16 at 3:37 PM
capitalcube.com logoETF’s with exposure to Athersys, Inc. : September 16, 2016 (NASDAQ:ATHX)
www.capitalcube.com - September 16 at 12:25 PM
News IconStock Update, a Closer Look at Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 15 at 8:49 PM
seekingalpha.com logoAll Systems Go On Athersys Pivotal Stem Cell Stroke Trial In Japan - Exploring The Scientific Evidence (NASDAQ:ATHX)
seekingalpha.com - September 15 at 12:32 PM
News IconKeen Investors Narrowing Their Focus on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 14 at 8:52 PM
News IconPenny Stock Investors Highly Curious in Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 13 at 3:35 PM
News IconInvestor Scope: Checking in on Shares of Athersys, Inc. (NASDAQ:ATHX) - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 13 at 3:35 PM
News IconStock Update on Earnings & Estimates for Athersys, Inc. (NASDAQ:ATHX) - Frisco Fastball (NASDAQ:ATHX)
friscofastball.com - September 13 at 8:29 AM
News IconGetting a Closer Look at Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 12 at 3:37 PM
News IconShares Higher in Current Session: Athersys, Inc. (NASDAQ:ATHX) - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 12 at 3:37 PM
smarteranalyst.com logoCompany Update (NASDAQ:ATHX): Athersys, Inc. Announces Acceptance by PMDA of Clinical Trial Notification in ... - Smarter Analyst (NASDAQ:ATHX)
www.smarteranalyst.com - September 12 at 3:37 PM
investopedia.com logoAthersys to Start Stroke Treatment Trials (ATHX) (NASDAQ:ATHX)
www.investopedia.com - September 12 at 3:37 PM
streetinsider.com logoAthersys (ATHX) Announces Approval in Japan to Conduct MultiStem Safety, Efficacy Trial - StreetInsider.com (NASDAQ:ATHX)
www.streetinsider.com - September 12 at 8:24 AM
finance.yahoo.com logo6:31 am Athersys announces successful completion of Japan's Pharmaceutical and Medical Devices Agency review of the Clinical Trial Notification allowing the commencement by HEALIOS of a confirmatory clinical trial evaluating the safety and (NASDAQ:ATHX)
finance.yahoo.com - September 12 at 8:24 AM
biz.yahoo.com logoATHERSYS, INC / NEW Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ATHX)
biz.yahoo.com - September 12 at 8:24 AM
publicnow.com logoAthersys Announces Acceptance by PMDA of Clinical Trial Notification in Japan for Treatment of Ischemic Stroke With MultiStem® (NASDAQ:ATHX)
www.publicnow.com - September 12 at 8:24 AM
News IconFocusing the Spotlight on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 9 at 3:35 PM
News IconMaking News: Targeting shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 9 at 3:35 PM
News IconMarket Review: Watching Session Activity of Athersys, Inc. (NASDAQ:ATHX) Shares - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 9 at 3:35 PM
News IconThe Sell-side Consensus is in on Athersys, Inc. (NASDAQ:ATHX); Earnings & Target Updates - National Daily Press (NASDAQ:ATHX)
www.nationaldailypress.com - September 9 at 3:35 PM
News IconTrading Update: Following Activity of Athersys, Inc. (NASDAQ:ATHX) Shares During the Current Session - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 7 at 3:36 PM
News IconNarrowing the Lens on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 7 at 3:36 PM
News IconOTC Investors Supremely Interested in Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 6 at 3:41 PM
News IconBiotech Stocks To Put On Your Watch List: Athersys, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ATHX)
voiceregistrar.com - September 6 at 3:41 PM
capitalcube.com logoETF’s with exposure to Athersys, Inc. : September 6, 2016 (NASDAQ:ATHX)
www.capitalcube.com - September 6 at 3:41 PM
News IconA Second Look at Shares of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 2 at 3:38 PM
News IconInvestor Beat: Watching Activity of Athersys, Inc. (NASDAQ:ATHX) Shares During the Session - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 2 at 3:38 PM
News IconMarket Checkup: Performance Review on Shares of Athersys, Inc. (NASDAQ:ATHX) - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - September 1 at 3:37 PM
News IconUnder the Magnifying Glass: A Closer Look at Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - September 1 at 3:37 PM
News IconTaking a Serious Look at Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - August 31 at 3:35 PM
News IconZeroing Our Focus on Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - August 30 at 3:37 PM
News IconInvestors are Sharpening Their Focus on Shares of Athersys, Inc. (NASDAQ:ATHX) - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - August 30 at 3:37 PM
investornewswire.com logoAthersys, Inc. (NASDAQ:ATHX) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ATHX)
www.investornewswire.com - August 26 at 3:36 PM
News IconLooking Closer at Stocks of Athersys, Inc. (NASDAQ:ATHX) - Duncan Research (NASDAQ:ATHX)
www.duncanindependent.com - August 24 at 3:37 PM
News IconStreet Consensus on Athersys, Inc. (NASDAQ:ATHX) - Post News (NASDAQ:ATHX)
www.kentuckypostnews.com - August 24 at 3:37 PM

Social

Athersys (NASDAQ:ATHX) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff